Marieke Kruip

Marieke Kruip is a researcher at Erasmus MC in the department of Hematology. Her work focuses on thrombosis research, hemostasis, and blood disorders with particular emphasis on anticoagulant therapies, bleeding disorders, and the impact of infectious diseases like COVID-19 on vascular health. She has contributed to over 221 peer-reviewed publications, including recent studies on vitamin K antagonist treatment validation, national bleeding disorder practices, and thromboembolism epidemiology during the pandemic. Her research integrates clinical pharmacology, epidemiology, and translational medicine to address critical gaps in bleeding disorder management and anticoagulant therapy optimization.

• Key focus areas: Hematology, Thrombosis, Clinical Pharmacology
• Recent projects: Vitamin K antagonist efficacy validation, national bleeding disorder surveys, pandemic-related thromboembolism trends

Her collaborative work involves multidisciplinary teams addressing bleeding disorders, anticoagulation strategies in terminal patients, and sex-based differences in pulmonary embolism outcomes. Supervised 7 doctoral theses focusing on hemostasis mechanisms and clinical drug exposure analysis.